Post Marketing Study of Safety and Efficacy of Crystalys, a Calcium Hydroxyapatite Based Filler for Facial Soft Tissue Augmentation
In this post marketing study our primary objective was to assess the safety of Crystalys, a new calcium hydroxyapatite based filler, in subjects who received sub-dermal or deep-dermal injections for facial soft tissue augmentation. The secondary objective was to evaluate the performance of Crystalys within six months of injection.
Hologic Completes Acquisition of Cynosure
„We are pleased to complete our acquisition of Cynosure, and look forward to working with Michael Davin and the entire Cynosure team to achieve even greater success in the large, rapidly growing medical aesthetics market,“ said Steve MacMillan, Hologic‘s Chairman, President and Chief Executive Officer. „Acquiring Cynosure, combined with divesting our blood screening business, fundamentally reshapes our business portfolio and makes us […]
– Net Sales +2.7%, benefiting from contribution of new businesses – Growth driven by Dermatology +13.3%, which now accounts for 43% of sales vs. 39% in Q1 15 – Product mix drove Gross Margin improvement of +40bps – Integration of new businesses on track – R&D pipeline continues to progress: 3 Phase III programs – […]
Almirall and Bicosome enter into a collaboration and sublicense agreement for the development of topical drug delivery formulations
Almirall S.A., the global pharmaceutical company based in Barcelona, and Bicosome, a start-up company that develops and commercializes high performance cosmetic and dermopharmaceutical ingredients, announced that they have entered into a research, collaboration and sublicense agreement for the development of multiple topical dermatological products, based upon Bicosome’s proprietary patented delivery technology platform, Bicosome® Technology. In […]